Invitrogen™ Human Caspase 7 Synthetic Peptide

Description

• Caspase-7 Synthetic Peptide, PEP-0233, from Invitrogen
• Caspase 7 is part of a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies
• Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens
• The apoptotic subfamily can be further divided into initiator caspases, which are activated in response to death signals, and executioner caspases, which are activated by the initiator caspases and are responsible for cleavage of cellular substrates that ultimately lead to cell death
• Caspase 7 is an executioner caspase that was identified based on its homology with caspases 1 and 3, as well as the C
• elegans cell death protein CED-3
• Alternative splicing of Caspase-7 mRNA results in the production of 3 distinct isoforms
• Caspase-7 activity can be directly inhibited by XIAP expression
• Alternative splicing results in four transcript variants, encoding three distinct isoforms of Caspase 7
• Diseases associated with CASP7 include Type 1 Diabetes Mellitus 17 and Aleutian Mink Disease
• This peptide corresponds to 16 amino acids near the amino terminus of human caspase-7.PEP-0233 can be used as a blocking peptide with polyclonal antibody PA5-20115.